(Q36431547)

14 August 2017

A phase I/II study of a hypoxic cell radiosensitizer KU-2285 in combination with intraoperative radiotherapy (English)

1 reference

adaptive radiation therapy

14 August 2017

0 references

hypoxia

0 references

author name string

Shibamoto Y

1

1 reference

14 August 2017

Ohshio G

2

1 reference

14 August 2017

Hosotani R

3

1 reference

14 August 2017

Nishimura Y

4

1 reference

14 August 2017

Manabe T

5

1 reference

14 August 2017

Imamura M

6

1 reference

14 August 2017

Abe M

7

1 reference

14 August 2017

language of work or name

English

0 references

publication date

1 January 1997

1 reference

British Journal of Cancer

14 August 2017

1 reference

14 August 2017

76

1 reference

14 August 2017

11

1 reference

14 August 2017

1474-1479

1 reference

Clinical evaluation of nitroimidazoles as modifiers of hypoxia in solid tumors

14 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2228186

Clinical trials with hypoxic cell sensitizers: time to retrench or time to push forward?

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2228186

In vivo radiosensitization efficacy of KU-2285 and etanidazole at clinically relevant low radiation doses.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2228186

The role of misonidazole combined with intraoperative radiation therapy in the treatment of pancreatic carcinoma.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2228186

Pharmacokinetics of intratumoral RK-28, a new hypoxic radiosensitizer

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2228186

RTOG #89-06: a phase I study to evaluate intraoperative radiation therapy and the hypoxic cell sensitizer etanidazole in locally advanced malignancies.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2228186

Characteristics of fluorinated nitroazoles as hypoxic cell radiosensitizers

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2228186

High-dose intraoperative radiotherapy for unresectable pancreatic cancer

21 September 2018

1 reference

12 December 2020

Comparison of radiosensitizing effect of KU-2285 and SR-2508 at low drug concentrations and doses

1 reference

12 December 2020

Importance of tumor affinity of nitroazoles in hypoxic radiosensitization

1 reference

12 December 2020

Final report of the phase I trial of the hypoxic cell radiosensitizer SR 2508 (etanidazole) Radiation Therapy Oncology Group 83-03

1 reference

12 December 2020

A fluorinated 2-nitroimidazole, ku-2285, as a new hypoxic cell radiosensitizer

1 reference

12 December 2020

Results of an RTOG phase III trial (RTOG 85-27) comparing radiotherapy plus etanidazole with radiotherapy alone for locally advanced head and neck carcinomas

1 reference

12 December 2020

Hypoxic cell radiosensitizers: the end of an era? Regarding Lee et al., IJROBP 32:567-576; 1995

1 reference

12 December 2020

Optical isomers of a new 2-nitroimidazole nucleoside analog (PR-350 series): Radiosensitization efficiency and toxicity

1 reference

12 December 2020

Intraoperative radiotherapy and hyperthermia for unresectable pancreatic cancer

1 reference

12 December 2020

A phase I study of a hypoxic cell sensitizer KU-2285 in combination with conventional radiotherapy

1 reference

12 December 2020

Results of a phase II trial of external beam radiation with etanidazole (SR 2508) for the treatment of locally advanced prostate cancer (RTOG Protocol 90-20)

1 reference

12 December 2020

Radiosensitization efficacy of KU-2285, RP-170 and etanidazole at low radiation doses: assessment by in vitro cytokinesis-block micronucleus assay

1 reference

12 December 2020

A trial of Ro 03-8799 (pimonidazole) in carcinoma of the uterine cervix: an interim report from the Medical Research Council Working Party on advanced carcinoma of the cervix

1 reference

12 December 2020

Hypoxic cell sensitizers for radiotherapy

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1997.580

1 reference

Dimensions Publication ID

14 August 2017

0 references

1 reference

14 August 2017

PubMed publication ID

9400944

1 reference